Return On Assets in % of AGIOS PHARMACEUTICALS, INC. from Q1 2014 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
AGIOS PHARMACEUTICALS, INC. quarterly/annual Return On Assets history and change rate from Q1 2014 to Q3 2025.
  • AGIOS PHARMACEUTICALS, INC. Return On Assets for the quarter ending 30 Sep 2025 was -26.4 %, a 143% decline year-over-year.
  • AGIOS PHARMACEUTICALS, INC. annual Return On Assets for 2024 was 53.1 %.
  • AGIOS PHARMACEUTICALS, INC. annual Return On Assets for 2023 was -33.7 %, a 81.9% decline from 2022.
  • AGIOS PHARMACEUTICALS, INC. annual Return On Assets for 2022 was -18.5 %, a 121% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

AGIOS PHARMACEUTICALS, INC. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -26.4 -88.4 -143% 01 Jul 2025 30 Sep 2025
Q2 2025 40.1 +81 01 Apr 2025 30 Jun 2025
Q1 2025 46.1 +82.4 01 Jan 2025 31 Mar 2025
Q4 2024 53.1 +86.8 01 Oct 2024 31 Dec 2024
Q3 2024 62 +81.6 01 Jul 2024 30 Sep 2024
Q2 2024 -40.9 -22.9 -127% 01 Apr 2024 30 Jun 2024
Q1 2024 -36.4 -18.3 -101% 01 Jan 2024 31 Mar 2024
Q4 2023 -33.7 -15.2 -81.9% 01 Oct 2023 31 Dec 2023
Q3 2023 -19.6 +8.29 +29.7% 01 Jul 2023 30 Sep 2023
Q2 2023 -18.1 +8.53 +32.1% 01 Apr 2023 30 Jun 2023
Q1 2023 -18.1 +5.46 +23.2% 01 Jan 2023 31 Mar 2023
Q4 2022 -18.5 -106 -121% 01 Oct 2022 31 Dec 2022
Q3 2022 -27.9 -123 -129% 01 Jul 2022 30 Sep 2022
Q2 2022 -26.6 -131 -126% 01 Apr 2022 30 Jun 2022
Q1 2022 -23.6 -145 -119% 01 Jan 2022 31 Mar 2022
Q4 2021 87.4 +124 01 Oct 2021 31 Dec 2021
Q3 2021 94.8 +132 01 Jul 2021 30 Sep 2021
Q2 2021 104 +144 01 Apr 2021 30 Jun 2021
Q1 2021 121 +167 01 Jan 2021 31 Mar 2021
Q4 2020 -37 +14.5 +28.1% 01 Oct 2020 31 Dec 2020
Q3 2020 -37.2 +13.6 +26.7% 01 Jul 2020 30 Sep 2020
Q2 2020 -40.3 +5.57 +12.1% 01 Apr 2020 30 Jun 2020
Q1 2020 -45.2 -6.6 -17.1% 01 Jan 2020 31 Mar 2020
Q4 2019 -51.5 -15.3 -42.4% 01 Oct 2019 31 Dec 2019
Q3 2019 -50.7 -12.5 -32.5% 01 Jul 2019 30 Sep 2019
Q2 2019 -45.9 -6.98 -17.9% 01 Apr 2019 30 Jun 2019
Q1 2019 -38.6 +5.14 +11.7% 01 Jan 2019 31 Mar 2019
Q4 2018 -36.2 +11.9 +24.7% 01 Oct 2018 31 Dec 2018
Q3 2018 -38.3 -0.21 -0.55% 01 Jul 2018 30 Sep 2018
Q2 2018 -38.9 -2.85 -7.9% 01 Apr 2018 30 Jun 2018
Q1 2018 -43.8 -9.15 -26.4% 01 Jan 2018 31 Mar 2018
Q4 2017 -48.1 -18.6 -63.3% 01 Oct 2017 31 Dec 2017
Q3 2017 -38 -2.34 -6.55% 01 Jul 2017 30 Sep 2017
Q2 2017 -36.1 -0.96 -2.73% 01 Apr 2017 30 Jun 2017
Q1 2017 -34.6 -3.34 -10.7% 01 Jan 2017 31 Mar 2017
Q4 2016 -29.4 -3.53 -13.6% 01 Oct 2016 31 Dec 2016
Q3 2016 -35.7 -13.7 -62.6% 01 Jul 2016 30 Sep 2016
Q2 2016 -35.1 -21.1 -151% 01 Apr 2016 30 Jun 2016
Q1 2016 -31.3 -19 -155% 01 Jan 2016 31 Mar 2016
Q4 2015 -25.9 -8.3 -47.1% 01 Oct 2015 31 Dec 2015
Q3 2015 -22 -5 -29.5% 01 Jul 2015 30 Sep 2015
Q2 2015 -14 +10.8 +43.5% 01 Apr 2015 30 Jun 2015
Q1 2015 -12.3 +12.7 +50.8% 01 Jan 2015 31 Mar 2015
Q4 2014 -17.6 01 Oct 2014 31 Dec 2014
Q3 2014 -17 01 Jul 2014 30 Sep 2014
Q2 2014 -24.8 01 Apr 2014 30 Jun 2014
Q1 2014 -24.9 01 Jan 2014 31 Mar 2014

AGIOS PHARMACEUTICALS, INC. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 53.1 +86.8 01 Jan 2024 31 Dec 2024
2023 -33.7 -15.2 -81.9% 01 Jan 2023 31 Dec 2023
2022 -18.5 -106 -121% 01 Jan 2022 31 Dec 2022
2021 87.4 +124 01 Jan 2021 31 Dec 2021
2020 -37 +14.5 +28.1% 01 Jan 2020 31 Dec 2020
2019 -51.5 -15.3 -42.4% 01 Jan 2019 31 Dec 2019
2018 -36.2 +11.9 +24.7% 01 Jan 2018 31 Dec 2018
2017 -48.1 -12.7 -35.9% 01 Jan 2017 31 Dec 2017
2016 -35.4 -9.46 -36.5% 01 Jan 2016 31 Dec 2016
2015 -25.9 -8.3 -47.1% 01 Jan 2015 31 Dec 2015
2014 -17.6 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.